For selected applicants, the agency plans to cut review times down to one to two months and provide "tumor board-style" ...

In the growing rare disease precision medicine market, drug companies must avoid funding genetic testing that the Justice ...

NEW YORK – Archeus Technologies on Friday said the US Food and Drug Administration cleared its investigational new drug application (IND) for the theranostic radiopharmaceutical agent ART-101 in ...

Studies doing genome-wide testing can easily ID patients with naturally low neutrophil counts, but nobody's looking at it, ...

NEW YORK – Singapore's Ministry of Health announced this week it will launch a genetic testing program to improve diagnosis of familial hypercholesterolemia (FH) as part of a broader national focus on ...

The agency maintains that the beta-amyloid-targeting drugs show too limited benefit to justify their cost to the National Health Service.

Trump administration health officials assured drugmakers and researchers at a roundtable hosted by the FDA that they want to ...

Medical ethicists are bringing attention to an early chapter of precision medicine history, an often overlooked aspect of an ...

Only 6 percent of patients carried a concerning DPYD variant, but nearly two-thirds of them were later hospitalized after ...

NEW YORK – Researchers at the Cambridge University Hospital and The Royal Marsden Hospital in London have begun enrolling patients with malignant brain tumors into two genomically informed treatment ...